[go: up one dir, main page]

AU2003213718A1 - Method of producing antigens - Google Patents

Method of producing antigens

Info

Publication number
AU2003213718A1
AU2003213718A1 AU2003213718A AU2003213718A AU2003213718A1 AU 2003213718 A1 AU2003213718 A1 AU 2003213718A1 AU 2003213718 A AU2003213718 A AU 2003213718A AU 2003213718 A AU2003213718 A AU 2003213718A AU 2003213718 A1 AU2003213718 A1 AU 2003213718A1
Authority
AU
Australia
Prior art keywords
producing antigens
antigens
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213718A
Other versions
AU2003213718A8 (en
Inventor
Szu-Yi Chou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHOU SZU YI
Original Assignee
CHOU SZU YI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/231,213 external-priority patent/US20040001848A1/en
Priority claimed from US10/231,470 external-priority patent/US7101695B2/en
Priority claimed from US10/231,063 external-priority patent/US20030224476A1/en
Priority claimed from US10/231,114 external-priority patent/US7485438B2/en
Priority claimed from US10/231,298 external-priority patent/US20030219853A1/en
Application filed by CHOU SZU YI filed Critical CHOU SZU YI
Publication of AU2003213718A8 publication Critical patent/AU2003213718A8/en
Publication of AU2003213718A1 publication Critical patent/AU2003213718A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003213718A 2002-03-01 2003-03-03 Method of producing antigens Abandoned AU2003213718A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US36116602P 2002-03-01 2002-03-01
US60/361,166 2002-03-01
US36344502P 2002-03-08 2002-03-08
US60/363,445 2002-03-08
US10/231,470 2002-08-28
US10/231,213 US20040001848A1 (en) 2002-03-01 2002-08-28 Method of producing disease-specific antigens
US10/231,114 2002-08-28
US10/231,470 US7101695B2 (en) 2002-03-01 2002-08-28 Method of producing transglutaminase having broad substrate activity
US10/231,063 US20030224476A1 (en) 2002-03-01 2002-08-28 Method of producing transglutaminase reactive compound
US10/231,114 US7485438B2 (en) 2002-03-01 2002-08-28 Method of producing polyvalent antigens
US10/231,063 2002-08-28
US10/231,213 2002-08-28
US10/231,298 2002-08-28
US10/231,298 US20030219853A1 (en) 2002-03-01 2002-08-28 Method of cross-linking a compound
PCT/US2003/006661 WO2003074004A2 (en) 2002-03-01 2003-03-03 Method of producing antigens

Publications (2)

Publication Number Publication Date
AU2003213718A8 AU2003213718A8 (en) 2003-09-16
AU2003213718A1 true AU2003213718A1 (en) 2003-09-16

Family

ID=27792403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213718A Abandoned AU2003213718A1 (en) 2002-03-01 2003-03-03 Method of producing antigens

Country Status (2)

Country Link
AU (1) AU2003213718A1 (en)
WO (1) WO2003074004A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
JP2007522119A (en) * 2004-01-28 2007-08-09 キュリックス エーピーエス Conjugates of amyloid protein as vaccines for amyloid-related diseases
TW200726482A (en) * 2005-06-30 2007-07-16 Merck & Co Inc Method for preparing a covalently cross linked oligomer of amyloid beta peptides
SG10201706600VA (en) 2005-11-30 2017-09-28 Abbvie Inc Monoclonal antibodies and uses thereof
KR20080090408A (en) 2005-11-30 2008-10-08 아보트 러보러터리즈 Anti-Aβ globulomer antibody, antigen-binding residues thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of making the antibody, compositions comprising the antibody, uses of the antibody and methods of using the antibody
JP2010500886A (en) * 2006-08-18 2010-01-14 ノボ ノルディスク ヘルス ケア アーゲー Transglutaminase variants with improved specificity
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
CN103933606B (en) 2006-12-15 2016-08-24 生命连结有限公司 Gelatin-transglutaminase hemostatic dressings and encapsulant
JP2010518842A (en) * 2007-02-22 2010-06-03 ノボ ノルディスク ヘルス ケア アーゲー Transglutaminase variants with improved specificity
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US20110086014A1 (en) * 2008-06-18 2011-04-14 Ishay Attar Method for enzymatic cross-linking of a protein
CA2728187C (en) 2008-06-18 2014-04-29 Lifebond Ltd Improved cross-linked compositions
AU2010334412B2 (en) 2009-12-22 2016-02-04 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
CA2807012A1 (en) 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544638A (en) * 1984-05-18 1985-10-01 The Regents Of The University Of California Synthesis of cross-links in the helical domain of collagen using pyridoxal 5-phosphate and copper or iron
US6010871A (en) * 1994-09-29 2000-01-04 Ajinomoto Co., Inc. Modification of peptide and protein

Also Published As

Publication number Publication date
AU2003213718A8 (en) 2003-09-16
WO2003074004A2 (en) 2003-09-12
WO2003074004A3 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
AU2003248563A1 (en) Method of forming nanocrystals
AU2003242024A1 (en) Method of constructing antibody
AU2003205507A1 (en) Method of producing fabric
AU2003234419A1 (en) Method of forming manofluidic channels
AU2003220407A1 (en) Method of preparing polyestercarbonates
AU2003244005A1 (en) Method of producing honeycomb structures
AU2003244297A1 (en) Method of producing flat glass
AU2002242683A1 (en) Method for producing 1-octen
AU2003290909A1 (en) Method of producing silicon monocrystal
AU2003213718A1 (en) Method of producing antigens
AU2003277596A1 (en) Method of deuterization
AU2002244806A1 (en) Method for producing reduced-weight plasterboards
AU2003281530A1 (en) METHOD FOR PRODUCING Si
AU2002335569A1 (en) Method for producing cyclohexanone
AU2003231271A1 (en) Method of producing an soi wafer
AU2003215932A1 (en) Method of producing fuses
AU2003288536A1 (en) Method of producing cultured pearls
AU2002358637A1 (en) Method for producing deoxybenzoins
AU2003246225A1 (en) Method of producing mold
AU2003217706A1 (en) Methods of producing phosphitylated compounds
AU2003276825A1 (en) Method of immunotherapy
AU2003222584A1 (en) Method of producing organoacyloxysilanes
AU2003289462A1 (en) Method for producing ceramic structure
AU2003259377A1 (en) Method of forming pocketted springs
AU2003283271A1 (en) Method for producing cephalexin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase